Sinovac Receives RMB 20 Million Purchase Order For Healive From China’s Ministry Of Health To Vaccinate Earthquake Victims

Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, announced that the Ministry of Health has purchased approximately RMB 20 million (US$2.86 million) of the Company’s inactivated hepatitis A vaccine, Healive(R), to vaccinate people living in the disaster zone following the May 12th earthquake. Sinovac has delivered shipments of the Healive vaccine to Sichuan, Shanxi and Gansu provinces. Mr.

More: continued here

Filed under: Aid / Disasters on June 1st, 2008